Effect of 2-year nutritional supplementation on progression of age-related macular degeneration.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 19 3 2019
medline: 24 3 2020
entrez: 19 3 2019
Statut: ppublish

Résumé

To examine the effect of a long-term nutritional supplementation on age-related macular degeneration progression. In this prospective, double-blind, placebo-controlled study, 80 patients with intermediate age-related macular degeneration were randomized (2:1) to receive 1 tablet/day of a nutritional supplement containing a mixture of carotenoids, vitamins and omega-3 fatty acids or placebo. Age-related macular degeneration progression assessed by digital fundus photography (primary outcome) and best-corrected visual acuity were evaluated. Differences between arms were tested using chi-square test or Fisher's exact test. Seventy-four patients completed the follow-up at 24 months (48 in the treated arm and 26 in the placebo arm). An age-related macular degeneration progression was observed in the 2.1% of patients of the treated arm and in the 15.4% of patients in the placebo arm (p = 0.05, Fisher's exact test). Best-corrected visual acuity data alone were not statistically significant among groups. A clinically meaningful stabilization of intermediate age-related macular degeneration over a period of 2 years may be obtained by treating patients with a mixture of carotenoids, vitamins and omega-3 fatty acids.

Identifiants

pubmed: 30880442
doi: 10.1177/1120672119836007
doi:

Substances chimiques

Fatty Acids, Omega-3 0
Vitamins 0
Carotenoids 36-88-4

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

376-381

Auteurs

Alberto Piatti (A)

ASL TO5, Moncalieri, Italy.

Antonella Croce (A)

ASL Città di Torino, Torino, Italy.

Danilo Mazzacane (D)

ASST Pavia and Melegnano, Pavia, Italy.

Giovanni Traina (G)

ASL Toscana Nord Ovest, Pisa, Italy.

Lina Ambrosino (L)

ASL Napoli 1 Centro, Napoli, Italy.

Luigi Boni (L)

ASL Toscana Sud Est, Arezzo, Italy.

Luca Lisi (L)

ASL Roma 2, Rome, Italy.

Maria Caterina Cascella (MC)

ASL di Bari, presidio F. Iaia, Bari, Italy.

Alberto Grunberger (A)

ATS Sardegna, SASSL Nuoro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH